Edition:
United States

Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

9.49USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$9.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
125,121
52-wk High
$37.00
52-wk Low
$4.17

Chart for

About

Catalyst Biosciences, Inc., formerly Targacept, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing medicines to address serious medical conditions. The Company focuses its product development efforts in the fields of hemostasis, including the treatment of hemophilia and... (more)

Overall

Beta: 2.06
Market Cap(Mil.): $122.29
Shares Outstanding(Mil.): 11.94
Dividend: --
Yield (%): --

Financials

  CBIO.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -3.71 -- --
ROI: -27.55 13.18 12.83
ROE: -27.58 15.14 14.95

BRIEF-Catalyst Biosciences Reports Q1 Loss Per Share $0.56

* CATALYST BIOSCIENCES REPORTS FIRST QUARTER OPERATING & FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 03 2018

Earnings vs. Estimates